JUN 24, 2021 6:00 AM PDT

Gut-Healing Stem Cells to Treat HIV Infections

WRITTEN BY: Tara Fernandez

A new study has revealed how stem cells can be used to amplify immune responses to HIV, the virus that causes AIDS. The work, published in the journal JCI Insight, describes how the use of mesenchymal stem cells, or MSCs, can be used to support the immune system to fight off the virus and may serve as an alternative to current HIV therapeutic strategies.

"Impaired immune functions in HIV infection and incomplete immune recovery pose obstacles for eradicating HIV," explained the study’s senior author, Satya Dandekar from UC Davis. "Our objective was to develop strategies to boost immunity against the virus and empower the host immune system to eradicate the virus. We sought to repair, regenerate and restore the lymphoid follicles that are damaged by the viral infection."

HIV is known to begin replicating and creating viral “reservoirs” within the lymphoid tissue in the gut. Previously, Dandekar and their team had identified downstream effects of this viral attack in the gut which include leaky gut and the destruction of the gut’s resident T cells. Currently available antiretroviral drugs work by slowing down the replication of the virus, but they aren’t able to heal the damage to lymphoid tissues caused by the infection.

"The lymphoid follicles are organized structures where the long-term immune attack is launched against pathogens by generating antibody response targeting the virus. These important regions are functionally impaired very early following HIV infection," said Dandekar.

Using a rhesus macaque model of HIV infections, the team found that when administered post-infection, MSCs initiate the restoration of damaged gut tissue and support the immune system by triggering the production of HIV-specific antibodies and viral-killing T cells.

"Stem cells are good synergistic partner components with drugs. The antiretroviral drugs can stop the fire of the viral infection but cannot restore the forest of the lymphoid tissue compartment. The MSCs would rejuvenate the field and bring back immune vitality," commented Dandekar.

 


Sources: JCI Insight, EurekAlert.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 14, 2021
Health & Medicine
Another Benefit of Aspirin: Decreased Colorectal Cancer Risk When Started Early
JUN 14, 2021
Another Benefit of Aspirin: Decreased Colorectal Cancer Risk When Started Early
Valued for stroke and heart attack prevention, aspirin is also recommended for colorectal cancer prevention. A Harv ...
JUN 11, 2021
Cell & Molecular Biology
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
JUN 11, 2021
Bad Fat in the Tumor Microenvironment May Disrupt Killer T Cells
The immune system can detect and destroy pathogenic and cancerous cells, but sometimes those dangerous cells can evade t ...
JUN 28, 2021
Cell & Molecular Biology
Bringing Light to Extracellular Vesicles
JUN 28, 2021
Bringing Light to Extracellular Vesicles
Though originally thought of as strictly a waste disposal system, extracellular vesicles (EVs) have been shown to have m ...
SEP 03, 2021
Cell & Molecular Biology
Is a Venom-Like Molecule Involved in COVID-19 Mortality?
SEP 03, 2021
Is a Venom-Like Molecule Involved in COVID-19 Mortality?
Scientists have sought to learn more about why some people get severe COVID-19 while others have only mild cases. We kno ...
SEP 16, 2021
Cancer
Inspiring Hope during Childhood Cancer Awareness Month
SEP 16, 2021
Inspiring Hope during Childhood Cancer Awareness Month
Childhood cancers, also known as pediatric cancers, are diagnosed in patients up to 14 years old.  Estimates for 20 ...
SEP 12, 2021
Coronavirus
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
SEP 12, 2021
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
New research may have identified a potential treatment or preventive medication for SARS-CoV-2 and other viral infection ...
Loading Comments...